Novo Nordisk shares plummet over 20% on weight-loss drug sale slump
Published on 29/07/2025 - 16:24 GMT+2 ADVERTISEMENT Novo Nordisk shares fell by over 20% on Tuesday after the firm slashed its full-year guidance, blaming weaker…
Shares in Eli Lilly rise as Zepbound weight-loss study shows solid success
Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug maker also said more…